GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anhui Anke Biotechnology (Group) Co Ltd (SZSE:300009) » Definitions » EBITDA Margin %

Anhui Anke Biotechnology (Group) Co (SZSE:300009) EBITDA Margin % : 39.51% (As of Mar. 2025)


View and export this data going back to 2009. Start your Free Trial

What is Anhui Anke Biotechnology (Group) Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Anhui Anke Biotechnology (Group) Co's EBITDA for the three months ended in Mar. 2025 was ¥248 Mil. Anhui Anke Biotechnology (Group) Co's Revenue for the three months ended in Mar. 2025 was ¥629 Mil. Therefore, Anhui Anke Biotechnology (Group) Co's EBITDA margin for the quarter that ended in Mar. 2025 was 39.51%.


Anhui Anke Biotechnology (Group) Co EBITDA Margin % Historical Data

The historical data trend for Anhui Anke Biotechnology (Group) Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anhui Anke Biotechnology (Group) Co EBITDA Margin % Chart

Anhui Anke Biotechnology (Group) Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.40 17.41 39.55 35.69 36.53

Anhui Anke Biotechnology (Group) Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.40 36.56 33.24 17.09 39.51

Competitive Comparison of Anhui Anke Biotechnology (Group) Co's EBITDA Margin %

For the Biotechnology subindustry, Anhui Anke Biotechnology (Group) Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anhui Anke Biotechnology (Group) Co's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anhui Anke Biotechnology (Group) Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Anhui Anke Biotechnology (Group) Co's EBITDA Margin % falls into.


;
;

Anhui Anke Biotechnology (Group) Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Anhui Anke Biotechnology (Group) Co's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=926.516/2536.043
=36.53 %

Anhui Anke Biotechnology (Group) Co's EBITDA Margin % for the quarter that ended in Mar. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=248.434/628.755
=39.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anhui Anke Biotechnology (Group) Co  (SZSE:300009) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Anhui Anke Biotechnology (Group) Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Anhui Anke Biotechnology (Group) Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Anhui Anke Biotechnology (Group) Co Business Description

Traded in Other Exchanges
N/A
Address
No.9 Changjiang Road, Hefei High-tech Zone, Customs Road 669, Hefei, CHN, 230088
Anhui Anke Biotechnology (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceuticals and health-care products. The Company distributes its product in both domestic and overseas markets. The company operates in more than 30 provinces in China.
Executives
Zhao Hui Directors, executives
Zhou Yuan Yuan Directors, executives
Wang Yong Supervisors
Yao Jian Ping Executives
Wang Rong Hai Directors, executives
Song She Wu Directors, executives
Fu Yong Biao Directors, executives
Jiang Jun Pei Supervisors
Xu Zhen Shan Director
Lu Guang Xin Executives
Yan Xin Wen Executives
Lu Chun Yan Executives
Wu Rui Director
Fan Qing Lin Director
Wang Yong Bin Executives

Anhui Anke Biotechnology (Group) Co Headlines

No Headlines